N.J. Admin. Code § 13:39-13.6

Current through Register Vol. 56, No. 11, June 3, 2024

Section 13:39-13.6 - Informed consent for collaborative drug therapy management

(a) Written informed consent shall be obtained from each individual patient participating in collaborative drug therapy management. Both the physician and the pharmacist shall retain a copy of the patient's written informed consent. The written informed consent shall:

1. Contain the specific patient's name;

2. Identify the risks and benefits of collaborative drug therapy management, including the fact that services provided under collaborative drug therapy management may not be covered by the patient's insurance provider;

3. Identify the fact that covering physicians and/or pharmacists may be utilized in the collaborative drug therapy management of the patient's care;

4. Identify the patient's right to elect to participate in and withdraw from the collaborative drug therapy management; and

5. Be signed and dated by the patient.

N.J. Admin. Code § 13:39-13.6